Skip to main content
Relationships between the Nicotine Metabolite Ratio and a Panel of Exposure and Effect Biomarkers: Findings from Two Studies of U.S. Commercial Cigarette Smokers.
- Author(s): Carroll, Dana M;
- Murphy, Sharon E;
- Benowitz, Neal L;
- Strasser, Andrew A;
- Kotlyar, Michael;
- Hecht, Stephen S;
- Carmella, Steve G;
- McClernon, Francis J;
- Pacek, Lauren R;
- Dermody, Sarah S;
- Vandrey, Ryan G;
- Donny, Eric C;
- Hatsukami, Dorothy K
- et al.
Published Web Locationhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437528/pdf/nihms-1555324.pdf
No data is associated with this publication.
BackgroundWe examined the nicotine metabolite ratio's (NMR) relationship with smoking intensity, nicotine dependence, and a broad array of biomarkers of exposure and biological effect in commercial cigarette smokers.
MethodsSecondary analysis was conducted on two cross-sectional samples of adult, daily smokers from Wave 1 (2013-2014) of the Population Assessment of Tobacco Use and Health (PATH) Study and baseline data from a 2014-2017 randomized clinical trial. Data were restricted to participants of non-Hispanic, white race. The lowest quartile of NMR (<0.26) in the nationally representative PATH Study was used to distinguish slow from normal/fast nicotine metabolizers. NMR was modeled continuously in secondary analysis.
ResultsCompared with slow metabolizers, normal/fast metabolizers had greater cigarettes per day and higher levels of total nicotine equivalents, tobacco-specific nitrosamines, volatile organic componds, and polycyclic aromatic hydrocarbons. A novel finding was higher levels of inflammatory biomarkers among normal/fast metabolizers versus slow metabolizers. With NMR modeled as a continuous measure, the associations between NMR and biomarkers of inflammation were not significant.
ConclusionsThe results are suggestive that normal/fast nicotine metabolizers may be at increased risk for tobacco-related disease due to being heavier smokers, having higher exposure to numerous toxicants and carcinogens, and having higher levels of inflammation when compared with slow metabolizers.
ImpactThis is the first documentation that NMR is not only associated with smoking exposure but also biomarkers of biological effects that are integral in the development of tobacco-related disease. Results provide support for NMR as a biomarker for understanding a smoker's exposure and potential risk for tobacco-related disease.
Item not freely available? Link broken?Report a problem accessing this item